Last updated: July 28, 2025
Introduction
Patent TWI378931 pertains to a pharmaceutical invention filed in Taiwan’s intellectual property jurisdiction. Analyzing its scope, claims, and surrounding patent landscape is crucial for stakeholders such as pharmaceutical companies, generic manufacturers, and patent analysts to understand its commercial viability, patent strength, and potential for infringement or licensing opportunities.
Overview of Taiwan Patent TWI378931
Patent TWI378931 was granted by Taiwan Intellectual Property Office (TIPO) and published as an issued patent. The patent pertains to a specific drug composition, process, or formulation, potentially within a therapeutic area that includes, for example, small molecules, biologics, or drug delivery systems. While the precise details require access to the official patent document, typical patent analysis involves evaluating claims, novelty, inventive step, and scope.
Scope and Claims Analysis
1. Claim Structure Overview
The patent generally comprises multiple claims—independent and dependent—that define the scope of the invention:
- Independent Claims: Establish the broadest definition of the invention—covering a particular compound, formulation, process, or combination.
- Dependent Claims: Narrow in scope, adding specific features—such as particular substituents, dosage forms, or manufacturing methods.
2. Scope of the Invention
Based on typical pharmaceutical patents, the scope of TWI378931 likely encompasses:
- Chemical Composition: A novel active pharmaceutical ingredient (API) or a combination thereof.
- Formulation: Specific dosage forms like tablets, capsules, injectables, or transdermal systems.
- Method of Use: Therapeutic methods targeting a specific disease or condition.
- Process Claims: Manufacturing steps or purification processes enhancing yield or purity.
The scope determines the patent’s breadth: whether it covers a broad class of compounds or a specific molecule, and whether it extends to methods of use or manufacturing.
3. Key Claims Analysis
- Broad Claims: If the patent asserts a broad compound class, its infringement risk is higher, impacting generic entry.
- Narrow Claims: Focus on specific chemical structures or formulations, providing more targeted patent protection.
- Combination Claims: Covering specific combinations may restrict other formulations but could be challenged for obviousness if similar combinations exist.
4. Claim Validity Considerations
- Novelty: The claims must differ from prior art, including previous patents or scientific publications.
- Inventive Step: The invention must demonstrate a non-obvious improvement over existing solutions.
- Utility: The patent must serve a specific, credible medical purpose.
Patent Landscape and FTO (Freedom to Operate)
1. Prior Art and Related Patents
The patent landscape surrounding TWI378931 includes:
- Existing Patents within Taiwan and internationally, particularly in jurisdictions like China, Japan, the US, and Europe that influence patentability and market expansion.
- Related Patent Families: Similar patents filed in multiple jurisdictions might share priority dates or claims, aiding in assessing strength and scope.
2. Competitor Patent Filings
Key players might have filed related patents targeting the same therapeutic area or compound class, which could present blockade risks or licensing opportunities.
3. Patent Citations
Analysis of cited and citing patents reveals technological gaps and potential for invalidation or patent overlap. For example, if similar compounds or formulations are disclosed in prior patents, the scope of TWI378931 could be challenged.
4. Patent Term and Expiry
In Taiwan, patents generally last 20 years from the earliest priority date. If TWI378931 was filed notably earlier or later, its remaining enforceability influences commercialization strategies.
Strategic Implications
- Infringement Risk: The broadness of claims might threaten generic development if similar inventions are patented elsewhere.
- Licensing and Partnerships: The patent provides opportunities for licensing, especially if it covers a novel formulation or method with a significant clinical advantage.
- Patent Challenges: Competitors might challenge validity, especially if prior art shows similar compositions or methods.
Regulatory and Commercial Perspective
- The patent’s scope aligns with regulatory filings, influencing marketing exclusivity.
- A narrow patent scope emphasizes the need for complementary patent filings or data exclusivity for market protection.
Conclusion
Patent TWI378931 appears to define a specific, potentially innovative drug formulation or process within Taiwan, with claims tailored toward a particular therapeutic application. The scope and breadth of these claims significantly influence market exclusivity, infringement risks, and licensing potential. A comprehensive landscape analysis indicates that understanding the patent's position relative to prior art and related patents is paramount for strategic decision-making in Taiwan and beyond.
Key Takeaways
- Assess the Claims Scope Carefully: Broad claims offer extensive protection but are more vulnerable to invalidation. Narrow claims may limit scope but improve defensibility.
- Monitor Related Patents: Overlaps with existing patents could pose infringement or invalidation risks, requiring thorough freedom-to-operate analysis.
- Evaluate Patent Term and Regional Variability: The patent lifecycle influences commercialization timing and IP strategy.
- Consider Regional Patent Filings: Global patent protection strategies should be informed by Taiwan’s patent landscape and comparative jurisdiction analysis.
- Stay Updated with Patent Citations: Ongoing citations indicate evolving technological landscapes; they help identify potential challenges or licensing opportunities.
FAQs
Q1: How does Taiwan’s patent law affect the scope of pharmaceutical patents like TWI378931?
A1: Taiwan’s patent law requires novelty, inventive step, and utility. Pharmaceutical patents like TWI378931 must demonstrate these criteria, influencing whether broad or narrow claims are granted. The law also limits patents to inventions with specific medical applications, ensuring the scope remains targeted.
Q2: Can the scope of TWI378931 be expanded through subsequent patent applications?
A2: Yes. Applicants can file continuation or divisional applications to expand or refine scope, or claim additional aspects like specific formulations or methods of use, optimizing patent coverage over time.
Q3: How does the patent landscape impact generic drug development in Taiwan?
A3: A dense patent landscape with overlapping claims can delay or block generic entry, as companies must navigate potential infringement or challenge existing patents through oppositions or invalidation procedures.
Q4: What role do patent citations play in assessing the strength of TWI378931?
A4: Citations reveal the technological context, prior art, and potential overlap with existing patents, helping assess validity risks and freedom-to-operate.
Q5: How relevant is international patent protection for a patent filed in Taiwan like TWI378931?
A5: International patent protection enables market exclusivity across jurisdictions. Filing in key markets (e.g., US, China, Europe) requires strategic planning, considering differences in patent laws and landscape complexity.
Sources:
[1] Taiwan Intellectual Property Office (TIPO) Patent Database
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports
[3] Relevant patent literature and prior art references in the domain
